ThermoGenesis Holdings, Inc.
THMO
$0.00
$0.000.00%
| Weiss Ratings | THMO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | THMO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Fair | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | THMO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -1.75 | |||
| Price History | THMO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -- | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -100.00% | |||
| 90-Day Total Return | -100.00% | |||
| Year to Date Total Return | -100.00% | |||
| 1-Year Total Return | -100.00% | |||
| 2-Year Total Return | -100.00% | |||
| 3-Year Total Return | -100.00% | |||
| 5-Year Total Return | -100.00% | |||
| 52-Week High % Change | -100.00% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | THMO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.97 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Jan 31, 2025 | |||
| 52-Week High Price (Date) | Apr 08, 2024 | |||
| Valuation | THMO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 15.00 | |||
| Enterprise Value | 4.33M | |||
| Price/Earnings (TTM) | 0.00 | |||
| Earnings Per Share (TTM) | -4.99 | |||
| Earnings Per Share Growth | -76.68% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.00 | |||
| Price/Book (Q) | 0.00 | |||
| Enterprise Value/Revenue (TTM) | 0.45 | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -0.89 | |||
| Enterprise Value/EBIT | -0.71 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | THMO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 4.03M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | THMO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 916 858 5100 | |||
| Address | 2711 Citrus Road Rancho Cordova, CA 95742 | |||
| Website | www.thermogenesis.com | |||
| Country | United States | |||
| Year Founded | 1986 | |||
| Profitability | THMO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -63.32% | |||
| Profit Margin | -153.43% | |||
| Management Effectiveness | THMO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -25.50% | |||
| Return on Equity | -- | |||
| Income Statement | THMO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 9.61M | |||
| Total Revenue (TTM) | 9.61M | |||
| Revenue Per Share | $2.39 | |||
| Gross Profit (TTM) | 2.03M | |||
| EBITDA (TTM) | -4.87M | |||
| EBIT (TTM) | -6.09M | |||
| Net Income (TTM) | -14.75M | |||
| Net Income Avl. to Common (TTM) | -14.75M | |||
| Total Revenue Growth (Q YOY) | 6.42% | |||
| Earnings Growth (Q YOY) | 61.39% | |||
| EPS Diluted (TTM) | -4.99 | |||
| EPS Diluted Growth (Q YOY) | 88.67% | |||
| Balance Sheet | THMO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.18M | |||
| Cash Per Share (Q) | $0.29 | |||
| Total Current Assets (Q) | 4.35M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -1.09M | |||
| Current Ratio (Q) | 0.524 | |||
| Book Value Per Share (Q) | $0.12 | |||
| Total Assets (Q) | 10.09M | |||
| Total Current Liabilities (Q) | 8.30M | |||
| Total Debt (Q) | 7.57M | |||
| Total Liabilities (Q) | 11.17M | |||
| Total Common Equity (Q) | 975.00K | |||
| Cash Flow | THMO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -982.00K | |||
| Cash from Financing (TTM) | -82.00K | |||
| Net Change in Cash (TTM) | -4.68M | |||
| Levered Free Cash Flow (TTM) | -87.90K | |||
| Cash from Operations (TTM) | -3.61M | |||
